Recurrent Malignant Solid Neoplasm

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08916Afatinib1Recruiting1
DB08885Aflibercept1Recruiting1
DB08875Cabozantinib1Active Not Recruiting1
DB08875Cabozantinib1Recruiting1
DB01101Capecitabine1Recruiting1
DB08912Dabrafenib1Recruiting1
DB00762Irinotecan1Recruiting1
DB12340Navitoclax1Recruiting1
DB09035Nivolumab1Recruiting1
DB09037Pembrolizumab1Recruiting1
DB11759Pevonedistat1Recruiting1
DB06176Romidepsin1Recruiting1
DB11836Sapanisertib1Recruiting1
DB00398Sorafenib1Recruiting1
DB00853Temozolomide1Recruiting1
DB08911Trametinib1Recruiting1
DB00515Cisplatin1 / 2Recruiting1
DB06186Ipilimumab1 / 2Recruiting1
DB00762Irinotecan1 / 2Recruiting1
DB11740MK-17751 / 2Recruiting1
DB12117Mitometh1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB00642Pemetrexed1 / 2Recruiting1
DB11760Talazoparib1 / 2Recruiting1
DB00853Temozolomide1 / 2Recruiting1
DB08916Afatinib2Recruiting1
DB08875Cabozantinib2Recruiting1
DB00958Carboplatin2Recruiting1
DB08865Crizotinib2Recruiting1
DB08912Dabrafenib2Recruiting1
DB01254Dasatinib2Recruiting1
DB12282Defactinib2Recruiting1
DB12147Erdafitinib2Not Yet Recruiting1
DB12147Erdafitinib2Recruiting1
DB01590Everolimus2Recruiting1
DB12167LY-30234142Recruiting1
DB11740MK-17752Recruiting1
DB09035Nivolumab2Recruiting1
DB09074Olaparib2Not Yet Recruiting1
DB09074Olaparib2Recruiting2
DB09330Osimertinib2Recruiting1
DB09073Palbociclib2Recruiting1
DB06366Pertuzumab2Recruiting1
DB11689Selumetinib2Recruiting1
DB01268Sunitinib2Recruiting1
DB12887Tazemetostat2Recruiting1
DB00853Temozolomide2Recruiting1
DB08911Trametinib2Recruiting2
DB05773Trastuzumab emtansine2Recruiting1
DB07232Veliparib2Recruiting1
DB08881Vemurafenib2Recruiting2
DB08828Vismodegib2Recruiting1
DB13104X-3962Recruiting1